Oncology Is a Major Focus for Many AI Drug Discovery Companies, Reports IDTechEx
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically...
Phesi Big Data Analysis of Over 200,000 Hepatitis B and C Patients Identifies Typical...
Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has analyzed...
CPhI Report predicts record EBITDAs for CDMOs in 2022
Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs...
Pharmapack Report 2021: US leads on drug device innovation but trails Europe on sustainability
Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released...
Bachem reports excellent results for the first half-year 2021
Sales grow by 35.0% to CHF 239.1 million
EBITDA rises from CHF 53.0 million...
Samsung Biologics Reports Strong SecondQuarter 2021 Financial Results
Samsung Biologics , a leading contract development and manufacturing organization, announced strong financial results for...
Samsung Biologics Issues Its First Annual Sustainability Report
Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), published its first annual...
Analysis of more than 160,000 COVID-19 patients shows obesity is the biggest indicator for...
Virtual clinical development specialist, Phesi Inc., has today released findings from a significant analysis of...
Real-World Effectiveness And Safety of Teduglutide in Adult Short Bowel Syndrome: A Meta-analysis
Randomized clinical trials have demonstrated that teduglutide, a glucagon-like peptide-2 (GLP-2) analog, improves intestinal absorption...
Artificial Intelligence to play a role in Nutraceuticals industry, India to be a leading...
A global industry survey conducted by Nutrify, the world’s first and only nutraceuticals i2c (ideas...
